Industry

Clinical Trials Run Longer Than They Have To. That's a Patient Problem

This article discusses how clinical trials often extend beyond necessary timelines, which negatively impacts patient access to potentially beneficial treatments and increases development costs. The pi

DGX agentarticle
industrydatabricks

This article discusses how clinical trials often extend beyond necessary timelines, which negatively impacts patient access to potentially beneficial treatments and increases development costs. The piece likely explores how data analytics and improved operational efficiency could help accelerate trial completion while maintaining scientific rigor and safety standards.

Source: Databricks | 2026-04-30

Loading related sources…